Basics BioAge Labs, Inc. IPO Date: September 26, 2024 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $170.65M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.43% Avg Daily Range (30 D): $0.08 | 1.71% Avg Daily Range (90 D): $0.09 | 2.17% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .11M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 107 Avg Trade Size (Sh.) (30 D): 75 Avg Trade Size (Sh.) (90 D): 91 Institutional Trades Total Inst.Trades: 49 Avg Inst. Trade: $1.49M Avg Inst. Trade (30 D): $1.74M Avg Inst. Trade (90 D): $1.16M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.84M Avg Closing Trade (30 D): $4.13M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 267.75K     News Aug 15, 2025 @ 1:00 PM BioAge Labs Announces First Participant Dosed in P... Source: Bioage Labs Aug 7, 2025 @ 3:14 AM BioAge Labs (BIOA) Q2 Revenue Hits $2.4M Source: Na Mar 8, 2025 @ 12:34 PM BIOA LEGAL NEWS: A Class Action was filed on behal... Source: N/A Mar 5, 2025 @ 5:00 PM Deadline Alert: BioAge Labs, Inc. (BIOA) Investors... Source: N/A Mar 3, 2025 @ 9:00 PM BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $7.47 $-.6 $-.36 Diluted EPS $7.47 $-.6 $-.36 Revenue $ 3.86M $ 2.41M $ 1.45M Gross Profit $ $ $ Net Income / Loss $ -79.03M $ -21.56M $ -12.93M Operating Income / Loss $ -91.33M $ -24.77M $ -16.45M Cost of Revenue $ $ $ Net Cash Flow $ 61.22M $ -37.11M $ -96.85M PE Ratio 0.67